Vertex has doubled down on cell-based therapies for type 1 diabetes (T1D), buying ViaCyte in a $320 million deal that it says will accelerate development of its own candidate VX-880. The deal has ...

pggb builds pangenome variation graphs from a set of input sequences. A pangenome variation graph is a kind of generic multiple sequence alignment. It lets us understand any kind of sequence variation ...

For the automated version of GraphCL, please refer to https://github.com/Shen-Lab/GraphCL_Automated. For the extention of GraphCL to hypergraphs, please refer to ...